SHAKING THINGS UP IT'S A
COMPANY ON.
>> A MISSION TO DECENTRALIZE
CLINICAL TRIALS AND IT'S READY
TO GROW 20 MILLION DOLLARS IN A
SERIES A ROW
AND HOT THORN EFFECT WORKING TO
ADDRESS KEY ISSUES RELATED TO
PATIENT RECRUITMENT
AND RETENTION YEAH, IT'S TECH
PLATFORM AND NETWORK OF
PROFESSIONALS, JOINING ME NOW
IS JODIE AIKEN FOUNDER AND CEO
POP ART EFFECT
AT JODI IT'S GREAT TO HAVE YOU
WITH US THIS AFTERNOON TALK TO
ME MORE ABOUT YOUR COMPANY AND
WHAT YOU PLAN TO DO WITH THIS
FUNDING.
>> YES, THANK YOU FOR HAVING IN
EFFECT AS A TECHNOLOGY ENABLED
SERVICE PLATFORM THAT ENABLES
PATIENTS
TO PARTICIPATE IN CLINICAL
TRIALS REGARDLESS OF THE USUAL
BARRIERS WHICH COULD BE
LOGISTICS GEOGRAPHY
FINANCIAL CONSTRAINTS. EOC WITH
THE EQUITY DIVIDE THAT WE KNOW
SO MUCH
AND THE IDEA IS TO EXPAND THE
REACH A CLINICAL TRIAL. SO THAT
ANYONE CAN PARTICIPATE FROM
ANYWHERE.
>> HOW IS THE COMPANY IF IT IS
PLAYING INTO THE CLOSE THE
COVID CLINICAL TRIALS THAT
WE'VE BEEN SEEN AFTER AT THIS
PAST 14 MONTHS OR SO.
>> YES, THE COVID AND
PANDEMIC REALLY SHAWNA SPITE
SPOTLIGHT ON WHAT IT IS A
DECADES OLD PROBLEM WHICH IS
CLINICAL TRIAL ACCESS
AND CONTINUITY. SO THE PANDEMIC
DEFINITELY SORT OF.
BLEW OPEN THE EXCEPTION AND THE
ADOPTION OF REMOTE AND
DISTRIBUTED CLINICAL TRIALS.
WE ARE MANY COVID TRIALS, OUR
PARTICIPATION IN SEVERAL
OPERATION WORKS FEED THIS
ENABLES PATIENTS THAT OTHERWISE
WOULD NOT PARTICIPATE BE WHILE
THEY'RE HOSPITALIZED BE GIVEN
NEW TREATMENTS AND THEN FOLLOW
OVER TIME REGARDLESS OF WHERE
THEY LIVE OR THEIR
LIFE CIRCUMSTANCES.
>> HOW DO PEOPLE ACCESS THIS
JODI HOPEFULLY THE END THIS
INTERVIEW PEOPLE WILL BECOME
MORE FAMILIAR WITH THE COMPANY
THE HAWTHORNE EFFECT IF THEY
AREN'T ALREADY DO THEY JUST
DOWNLOAD AN APP HOW DID THEY
ENTER THE SYSTEM.
>> WELL CLINICAL TRIALS ARE A
FAIRLY CADE ECOSYSTEM WE WORK
WITH THE A CLINICAL
INSTITUTIONS OF
WHOM USE.
>> OUR PLATFORM TO ENROLL AND
REGISTER PATIENTS OR WE WORK
WITH THE DRUG AND MEDICAL
DEVICE MANUFACTURER, THE
SPONSORS OF
POLITICAL RESEARCH AND USE OUR
PLATFORM TO ENABLE THEIR
PATIENTS TO PARTICIPATE IN THE
FUTURE WE DO SEE A DIRECT A
>> EVOLUTION WHAT'S WHAT'S IN
IT FOR THE PATIENT. I THINK YOU
KNOW MAYBE SOME PEOPLE
ARE WATCHING THEY'RE AT HOME,
THEY'RE WONDERING SHOULD I
SHOULD I BE A PART THESE WHAT'S
IN IT FOR
THEM, YES.
>> OH MY I ONE OF MY PASSIONS
AND I'VE BEEN 30 YEARS IN
CLINICAL AILES LEADING CLINICAL
TRIALS ALL OVER
THE WORLD I THINK THE AVERAGE
CITIZEN PATIENT FRIEND OR
FAMILY DOES IT REALLY
LIES THAT CLINICAL TRIALS, NOT
ONLY ENABLE ACCESS TO EARLY AN
INNOVATIVE TREATMENTS, BUT
THEIR PARTICIPATION ACTUALLY
CONTRIBUTES TO MILLIONS AND
BILLIONS OF PEOPLE GETTING
BETTER
HEALTH CARE. THE BEST EXAMPLE
OF THAT IS THE FACT WE HAVE
SHOTS IN ARMS FROM THE PANDEMIC
THAT THE NATION'S AT THE 30,000
PATIENTS DIDN'T PARTICIPATE
LAST SUMMER NOT ONLY WOULD THEY
NOT HAVE GOTTEN IMMUNITY EARLY
BUT WE WOULDN'T BE WHERE WE ARE
TODAY IN OUR VACCINATION
PROGRAM SO I WOULD LOVE THE
WORLD TO KNOW THAT
PARTICIPATING IN
ANY TRIAL. REALLY CONTRIBUTES
NOT ONLY TO THEIR OWN HEALTH
JOURNEY, BUT TO MILLIONS
OF OTHERS.
>> TALKED TO BE MORE ABOUT THE
GROWTH TRAJECTORY AFTER I'M
HERE FOR YOUR COMPANY.
>> SO HOW DOES THAT AFFECT HAS
ACTUALLY GROWN REALLY
BEAUTIFULLY ORGANICALLY
WELL AS WITH ACADEMIC
INSTITUTIONS
AND SPONSORS THE 20 MILLION IS
REALLY GOING TO HELP US REALLY
ACCELERATE OR GROSS.
BECAUSE THE PLATFORM AND
ECOSYSTEM IS VERY MUCH READY
FOR SCALE.
>> AND IN TERMS OF AD THIS NEW
FUNDING IS THAT GOING TO BE
FUNNELED DIRECTLY INTO 2 NEW
TASK HIRING MORE PEOPLE HOW
MIGHT SEE THAT REALIZED
IMMEDIATELY.
>> DEFINITELY IT'S ALL GOING
TOWARDS AND OF COURSE THERE
WILL ALWAYS BE ADVANCEMENTS AND
IN OUR TECHNOLOGY. WE DO HAVE A
SOMEWHAT OF A REVERSE
ENGINEERED TECHNOLOGY THAT DOES
MAKE.
THIS POSSIBLE TO DISTRIBUTE
CLINICAL TRIALS AND MUCH MORE
BROAD SO IN GROWS AND INDEED
THAT'S ONE OF
OUR 10.
>> JODY BECAUSE WE'VE HEARD THE
WARNING SIGNS OVER THE PAST 14
MONTHS THAT UNFORTUNATELY COVID
SITUATION COULD HAPPEN AGAIN IN
OUR LIFETIME AND WE MIGHT SEE
HAPPEN A FEW TIMES
UNFORTUNATELY IN
OUR LIFETIME. THE IMPORTANCE OF
THIS RIGHT AND GETTING MORE
PEOPLE FAMILIAR LOT
FAMILIARIZED WITH IT
THE MORE ACCESS THE MORE
CONNECTIVITY I THINK IT'S ALSO
IMPORTANT BUT I WANT YOU
TO PUT IN. DAN BECAUSE I THINK
COVID CAUGHT A LOT OF PEOPLE
OFF GUARD JUST HOW CRUCIAL IS
THIS AS WE MOVE FOR IN A
WORLD WHERE YOU KNOW WE MIGHT
SEE ANOTHER ONE OF THESE IN OUR
LIFETIME.
>> ABSOLUTELY I THINK THAT THE
TIME IS HERE AND NOW NOT ONLY
IN CLINICAL TRIALS, BUT IN
HEALTH CARE
AT ALL TO CREATE MORE
DISTRIBUTED MODELS FOR OF
INDIVIDUALS TO ACCESS AND SO
THESE KINDS OF DO RAISE THE
AWARENESS AND LOWER THE BARRIER
FOR ACCESS PARTICIPATION
WHETHER IT'S PARTICIPATING IN
TRIALS GETTING VACCINATIONS.
THE THE TECHNOLOGY
ENABLED ECOSYSTEM. AS YOU KNOW
A PART OF THIS IS A DISTRIBUTED
HEALTH NETWORK WE CALL AND
HAVING THEM IN THE ENABLE US
TO BE VERY MUCH SHOULD THE NEED
ARISE AGAIN NOT ONLY FOR TRIALS